These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Decreased platelet 5-hydroxytryptamin (5-HT) levels: a response to antidepressants. Li X, Fan Y, Xiao S, Peng S, Dong X, Zheng X, Liu CC, Li H, Xiao Z. J Affect Disord; 2015 Nov 15; 187():84-90. PubMed ID: 26321259 [Abstract] [Full Text] [Related]
30. The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram. Arborelius L, Nomikos GG, Hertel P, Salmi P, Grillner P, Höök BB, Hacksell U, Svensson TH. Naunyn Schmiedebergs Arch Pharmacol; 1996 May 15; 353(6):630-40. PubMed ID: 8738296 [Abstract] [Full Text] [Related]
31. Pharmacokinetic and pharmacodynamic responses to chronic administration of the selective serotonin reuptake inhibitor citalopram in rats. Wikell C, Apelqvist G, Carlsson B, Hjorth S, Bergqvist PB, Kugelberg FC, Ahlner J, Bengtsson F. Clin Neuropharmacol; 1999 May 15; 22(6):327-36. PubMed ID: 10626092 [Abstract] [Full Text] [Related]
32. Antidepressants targeting the serotonin reuptake transporter act via a competitive mechanism. Apparsundaram S, Stockdale DJ, Henningsen RA, Milla ME, Martin RS. J Pharmacol Exp Ther; 2008 Dec 15; 327(3):982-90. PubMed ID: 18801947 [Abstract] [Full Text] [Related]
33. S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine. Millan MJ, Gobert A, Lejeune F, Newman-Tancredi A, Rivet JM, Auclair A, Peglion JL. J Pharmacol Exp Ther; 2001 Aug 15; 298(2):565-80. PubMed ID: 11454918 [Abstract] [Full Text] [Related]